These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 11845135)

  • 21. Cardiovascular abnormalities in the athlete: recommendations regarding eligibility for competition. Task force II: Acquired valvular heart disease.
    Cheitlin MD; Bonow RO; Parmley WW; Roberts WC; Swan HJ; Williams JF
    J Am Coll Cardiol; 1985 Dec; 6(6):1209-14. PubMed ID: 2856840
    [No Abstract]   [Full Text] [Related]  

  • 22. Transesophageal echocardiography and evaluation of valvular heart disease.
    Aronson S; Heller L
    Int Anesthesiol Clin; 2004; 42(1):83-96. PubMed ID: 14716198
    [No Abstract]   [Full Text] [Related]  

  • 23. [Peculiarities of the phonocardiographic characteristics in mitral-aortic defects of the heart].
    Mel'nikov VG
    Kardiologiia; 1969 Jan; 9(1):65-8. PubMed ID: 5806212
    [No Abstract]   [Full Text] [Related]  

  • 24. Clinical aspects of acquired valvular heart disease.
    Fowler NO
    Semin Roentgenol; 1979 Apr; 14(2):83-95. PubMed ID: 462200
    [No Abstract]   [Full Text] [Related]  

  • 25. Preoperative markers of postoperative persistent severe left ventricular dysfunction.
    Rudolph W; Kraus F; Rudolph C
    Z Kardiol; 1986; 75 Suppl 2():90-4. PubMed ID: 3727723
    [No Abstract]   [Full Text] [Related]  

  • 26. Pulmonary perfusion imaging applied to prediction of pulmonary vascular pressures in mitral and aortic valve disease.
    Harris DN; Taylor DN; Rao KS; Conway N; Ackery DM
    Br Heart J; 1981 Dec; 46(6):643-6. PubMed ID: 7317232
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The "myocardial factor" in valvular heart diseases.
    Selzer A; Cohn K
    Cardiovasc Clin; 1973; 5(2):177-89. PubMed ID: 4273368
    [No Abstract]   [Full Text] [Related]  

  • 28. [Comparison and validation of echo-Doppler studies and hemodynamic studies in valvular cardiopathies].
    Felis S; Feraco E; Calvi V; Tamburino C; Drago A; Grassi R; Monaco A; Russo G; Lomeo A; Abbate M
    Cardiologia; 1987 Nov; 32(11):1463-71. PubMed ID: 3447709
    [No Abstract]   [Full Text] [Related]  

  • 29. [Cesarean section in severe double valvular disease].
    Ilkjaer S; Jakobsen CJ
    Ugeskr Laeger; 1996 Apr; 158(18):2552-3. PubMed ID: 8686010
    [TBL] [Abstract][Full Text] [Related]  

  • 30. AANA Journal course: update for nurse anesthetists--anesthetic techniques for patients with valvular heart disease presenting for noncardiac procedures.
    Pemerton AT
    AANA J; 1993 Jun; 61(3):315-24. PubMed ID: 8291393
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Cardiac dynamics time intervals during physical exertion in patients with acquired and congenital heart defects].
    Lang E; Krauss B
    Z Kreislaufforsch; 1970 Feb; 59(2):145-53. PubMed ID: 5419669
    [No Abstract]   [Full Text] [Related]  

  • 32. Rest and exercise radionuclide ventriculography in the ambulatory monitoring of patients with valvular heart disease.
    Raichlen JS; Brest AN
    Cardiovasc Clin; 1988; 18(3):193-207. PubMed ID: 3282664
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Methodologic issues in clinical evaluation of stenosis severity in adults undergoing aortic or mitral balloon valvuloplasty. The NHLBI Balloon Valvuloplasty Registry.
    Otto CM; Davis KB; Holmes DR; O'Neill W; Ferguson J; Bashore TM; Bonan R
    Am J Cardiol; 1992 Jun; 69(19):1607-16. PubMed ID: 1598878
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Genesis of mitral murmurs. II. Mitral diastolic murmurs: study with ultrasonics].
    Yuste P; Aza V; Minguez I; Asin E; Martínez-Bordiu C
    Arch Inst Cardiol Mex; 1974; 44(23):88-94. PubMed ID: 4837964
    [No Abstract]   [Full Text] [Related]  

  • 35. Physiological assessment of the physical performance of the patients with acquired valvular heart disease.
    Kozlowski S; Kontowt A; Dorywalski A
    Pol Med J; 1970; 9(4):820-6. PubMed ID: 5477488
    [No Abstract]   [Full Text] [Related]  

  • 36. Hemodynamic effects of muscle relaxant drugs during anesthetic induction in patients with mitral or aortic valvular heart disease.
    Larach DR; Hensley FA; Martin DE; High KM; Rung GW; Skeehan TM
    J Cardiothorac Vasc Anesth; 1991 Apr; 5(2):126-31. PubMed ID: 1677822
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased blood volume in cardiac valvar disease.
    Schechter DC; Gollub S
    Surg Gynecol Obstet; 1968 Dec; 127(6):1249-56. PubMed ID: 5727970
    [No Abstract]   [Full Text] [Related]  

  • 38. Evaluation of valvular heart disease in patients older than age 65.
    Kotler MN; Jacobs LE
    Cardiovasc Clin; 1992; 22(2):75-96. PubMed ID: 1586928
    [No Abstract]   [Full Text] [Related]  

  • 39. [Flow-dynamical factors of mechanical hemolysis in malformations of the cardiac valves].
    Bleifeld W; Kramer C; Pelzer H
    Thoraxchir Vask Chir; 1973 Apr; 21(2):130-5. PubMed ID: 4542526
    [No Abstract]   [Full Text] [Related]  

  • 40. Left predominant coronary circulation in patients with valvular aortic stenoses.
    Kober G; Klepzig H; Kaltenbach M
    Clin Cardiol; 1986 Aug; 9(8):383-7. PubMed ID: 3731564
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.